Candel Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.

About CADL

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110.

CEO

Paul-Peter Tak

CEOPaul-Peter Tak

Employees

Employees38

Headquarters

Needham, Massachusetts

HeadquartersNeedham, Massachusetts

Founded

2002

Founded2002

Employees

Employees38

CADL Key Statistics

Market cap

257.53M

Market cap257.53M

Price-Earnings ratio

-3.83

Price-Earnings ratio-3.83

Dividend yield

—

Dividend yield—

Average volume

817.95K

Average volume817.95K

High today

$5.44

High today$5.44

Low today

$5.03

Low today$5.03

Open price

$5.28

Open price$5.28

Volume

726.65K

Volume726.65K

52 Week high

$14.60

52 Week high$14.60

52 Week low

$3.79

52 Week low$3.79

People also own

Based on the portfolios of people who own CADL. This list is generated using Robinhood data, and it’s not a recommendation.